| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Prometheus Biosciences, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 113,677 | 14 Nov 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919121064934-luo-allison-2021-11-14 | Prometheus Biosciences, Inc. | 14 Nov 2021 | 1 | $0 | 4 | Chief Medical Officer | 16 Nov 2021, 20:06 |
| /report/000120919121056265-luo-allison-2021-09-08 | Prometheus Biosciences, Inc. | 08 Sep 2021 | 1 | $0 | 4 | Chief Medical Officer | 15 Sep 2021, 20:09 |